CATHERINE SALSBERRY: Open Payments
NPI 1679129985 · ROCK ISLAND, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,312 in 38 payments from 12 companies in 2025. Trend: 2023 $12,965 · 2024 $3,077 · 2025 $6,312
Speaker / faculty: $5,500Food & beverage: $643Travel & lodging: $169
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $5,948 |
| Neurocrine BioSciences, Inc. | 1 | $72 |
| Alkermes, Inc. | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 1 | $37 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| Galderma Laboratories, L.P. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: VRAYLAR, INGREZZA, ARISTADA, ABILIFY ASIMTUFII, FANAPT, Qelbree, CAPLYTA, Auvelity.
Industry payments across IL — which companies pay providers there.
